All In MedTech

Device Trial Radar · NCT05771844

Home Sleep Therapy for Older Adults With MCI

Home Sleep Therapy System for Mild Cognitive Impairment

Last checked: Nov 20, 2026Latest source record: Feb 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Feb 8, 2023

Primary completion

Jun 1, 2026

Study completion Jun 1, 2026

Sponsor

Lead sponsor
Brain Electrophysiology Laboratory CompanyNot on our public-company list
Sponsor type
Industry
Collaborators
National Institute on Aging (NIA); Wake Forest University
First posted
Mar 16, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 40 years, up to 85 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to learn about the ability of non-invasive brain stimulation during sleep to enhance people's deep sleep and its potential benefit on memory in people with mild cognitive impairment via home use sleep therapy device (SleepWISP) as well as learn about biomarkers associated with Alzheimer disease (AD). The clinical trial aims to answer the following main questions: 1. Whether the non-invasive transcranial electrical stimulation (TES) delivered by SleepWISP could provide short-term enhancement of deep sleep in a single night in the target population. 2. Whether TES delivered by SleepWISP could enhance deep sleep over multiple nights in the target population. 3. Whether enhance on deep sleep could improve memory performance in the target population. Participants will be asked to wear non-invasive and painless devices that record their brain activity during sleep along with an actigraphy watch that measures their movement throughout the day. In addition, blood samples or nasal swab assays will be collected from participants multiple times during the study.

Conditions

  • Mild Cognitive Impairment
  • Sleep
  • Transcranial Electrical Stimulation
  • Machine Learning
  • Memory

Interventions

  • Transcranial Electrical StimulationDevice

    Oscillating electrical current

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Device UsabilityTime frame: Collected each day they use the Sleep WISP system, for three sessions over 10 days during Phase I of the study.

2 more outcomes with a free account

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Wake Forest University

    Winston-Salem, North Carolina · Not yet recruiting

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.